KATHLEEN HUBBARD: Open Payments
NPI 1073015293 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 40 payments from 10 companies in 2025. Trend: 2023 $1,394 · 2024 $1,314 · 2025 $1,349
Food & beverage: $1,349
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $499 |
| Novartis Pharmaceuticals Corporation | 14 | $229 |
| Boston Scientific Corporation | 5 | $204 |
| AtriCure, Inc. | 1 | $156 |
| ABIOMED | 2 | $89 |
| Novo Nordisk Inc | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: REPATHA, LEQVIO, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, BodyGuardian, Wegovy, CDS - MCT/CEM Monitoring, ELIQUIS, INSPIRE.
Industry payments across TX — which companies pay providers there.
